drugset / Trial / NCT05298761
Efficacy of I/v Nalbuphine v/s Iv Lignocain in Attanuation of Pressor Responseduring Laryngeoscopy and Intubation in Middle Age Patient Planned for Thyroid Surgery
RandomizedParallel-groupSingle-blindHealth-services research
Summary
Comparison of I/V nalbuphine versus I/V xylocain in attanuation of pressor response during intubation and laryngeoscopy in patients undergoing for thyroid surgery,selection of better supressor agent minimises the drug repated side effects like hypertention tachycardia but also helps in heamodynamically stability at induction.
Timeline
- Start
- 2023-12-30
- Primary completion
- 2024-03-01
- Completion
- 2024-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 1.5 mg/kg | Intravenous |
| Subject | Nalbuphine | Small molecule | 0.1 mg/kg | Intravenous |
Indications
No indication recorded.